Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-10

Clinical Trial Update: VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating VNP40101M followed by cytarabine in older adults with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYTARABINE (CYTARABINE)
  • VNP40101M

Snippet

Sponsor: Vion Pharmaceuticals | Conditions: Leukemia | Phase 2 | Status: UNKNOWN